Skip to content

Parkinson's Disease Health Center

Font Size

Parkinson's Drugs: Heart Damage Link?

Researchers Raise Concerns About Damage to Heart Valves From 2 Parkinson's Drugs
WebMD Health News
Reviewed by Louise Chang, MD

Jan. 3, 2007 -- Two drugs used in the treatment of Parkinson's disease appear to increase the risk of heart valve disease, according to new research that also raises safety questions about similar-acting drugs.

The drugs pergolide, marketed as Permax, and cabergoline, sold as Dostinex, were associated with heart valve damage in two European studies published in the Jan. 4 issue of the New England Journal of Medicine.

Both drugs are in a class known as ergot-derived dopamine receptor agonists, and both have been linked to heart valve issues in earlier case reports.

"We showed that treatment with either pergolide or cabergoline for more than six months was strongly associated with an increase in valve-related heart disease," Edeltraut Garbe, MD, PhD, tells WebMD. "No increase in risk was seen in patients treated with other dopamine agonists."

Heart Valves and Parkinson's Drugs

Garbe and colleagues from a German research center compared treatment histories among Parkinson's disease patients who did and did not develop heart valve disease.

Heart valves are one-way valves that keep blood flowing in the right direction through your heart. If people have problems with their heart valves then blood may not move the way it should.

The study involved more than 11,000 patients prescribed anti-Parkinson drugs from the U.K. registered in a nationwide database.

The rate of heart valve disease was seven times higher than the rate in a matched comparison group of patients from the group who didn't develop heart valve disease among current pergolide-treated patients -- and five times higher among patients being treated with cabergoline. No increase was seen among current users of other types of dopamine-directed drugs.

Checking for Heart Valve Disease

In a separate study from Italy, researchers performed echocardiograms on Parkinson's patients being treated with either ergot-derived or nonergot-derived dopamine-targeting drugs. An echocardiogram is an ultrasound of the heart which can provide information on the heart's chambers and valves and how well blood is pumping through the heart.

Compared with an age-matched group without Parkinson's disease, patients taking pergolide or cabergoline had significantly more evidence of heart valve disease.

Clinically important evidence of valve damage was seen in roughly 5% of the comparison group, compared with 23% of patients taking pergolide and 28% of patients taking cabergoline.

Garbe says it is clear from the two studies that patients taking either pergolide or cabergoline should be monitored closely for heart valve damage.

"We aren't saying that these drugs should not be used," she says. "I think if patients are appropriately followed they can be prescribed. But neurologists and other treating physicians have to be made aware of the risks."

A spokesman for pergolide manufacturer Valeant Pharmaceuticals International tells WebMD that the company would have no direct comment on the two new studies. But a company statement reaffirmed the safety of the drug.

"Permax (pergolide) is a safe and effective treatment for patients with Parkinson's disease," the statement reads. "Although Valeant no longer promotes the product, we still make it available for those who prescribe it. We also routinely communicate with the FDA and recently worked with the agency to modify the label to advise physicians that the product, like other dopamine agonists, should be used with caution."

Today on WebMD

Parkinsons disease illustration
Causes, symptoms, and treatments.
hands on walker
How does the disease progress?
man with serious expression
8 common questions and answers.
intelligence quotient illustration
What are the advantages of DBS?
Parkinsons Disease Medications
Questions Doctor Parkinsons
Eating Right
Parkinsons Exercise
daughter consoling depressed mother
senior man's hands
Parkinsons Daily